Earnings Releases·Nov 4, 2026, 6:31 AM ET

CVS Health — Third Quarter 2026 Earnings Summary

Total revenues rose 5.4% year-over-year to $108.4 billion, while GAAP diluted EPS recovered to $1.68 from a $3.13 loss in the prior year, and adjusted EPS increased to $2.09 from $1.60.
Full-year 2026 guidance was raised across key metrics: GAAP EPS to at least $6.98, adjusted EPS to at least $8.20, and operating cash flow to at least $15.5 billion.
The Health Care Benefits segment saw adjusted operating income surge to $912 million from $314 million, while Pharmacy & Consumer Wellness revenue declined 2.0% to $35.5 billion despite a 10.6% rise in adjusted operating income.
Management maintains a cautious outlook for the remainder of the year due to elevated cost trends and macro headwinds, though the prior year's $5.7 billion goodwill impairment charge is absent in current results.